References
- HammarstenJPeekerRUrological aspects of the metabolic syndromeNat Rev Urol20118948349421811224
- LeeRKChungDChughtaiBTeAEKaplanSACentral obesity as measured by waist circumference is predictive of severity of lower urinary symptomsBJU Int201211054054522243806
- KaplanSFischHBerrimanSJCentral obesity as measured by waist circumference is predictive of severity of lower urinary tract symptoms, sexual dysfunction, and components of the metabolic syndrome [abstract 1508]J Urol20071774suppl497498
- Global Database on Body Mass Index: an interactive surveillance tool for monitoring nutrition transition [webpage on the Internet]GenevaWorld Health Organization2006 [updated March 25, 2013]. Available from: http://apps.who.int/bmi/index.jspAccessed August 22, 2012
- Al-NozhaMMAl-MazrouYYAl-MaatouqMAObesity in Saudi ArabiaSaudi Med J20052682482915951877
- NgSWZaghloulSAliHIHarrisonGPopkinBMThe prevalence and trends of overweight, obesity and nutrition-related non-communicable diseases in the Arabian Gulf StatesObes Rev201112111320546144
- Al-NozhaMMAl-MaatouqMAAl-MazrouYYDiabetes mel-litus in Saudi ArabiaSaudi Med J200425111603161015573186
- Al-NozhaMMAbdullahMArafaMRHypertension in Saudi ArabiaSaudi Med J2007281778417206295
- KumosaniTAAlamaMNIyerACardiovascular diseases in Saudi ArabiaPrime Research on Medicine2011116
- Al-NozhaMAl-KhadraAArafahMRMetabolic syndrome in Saudi ArabiaSaudi Med J200526121918192516380773
- MosliHAFarsiHMAAl-ZimaityMFEvaluation of a symptom score index for measurement of lower urinary symptoms in Arabic formSaudi Med J1995166536542
- RhodenELTelökenCSogariPRVargas SoutoCAThe use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunctionInt J Impot Res20021424525012152112
- GrundySMCleemanJIDanielsSRAmerican Heart AssociationNational Heart, Lung, and Blood InstituteDiagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung and Blood Institute Scientific StatementCirculation2005112172735275216157765
- World Health OrganizationWaist Circumference and Waist–Hip Ratio Report of a WHO Expert ConsultationGeneva8–11 December 2008
- GrundySMObesity, metabolic syndrome, and cardiovascular diseaseJ Clin Endocrinol Metab20048962595260015181029
- GacciMVignozziLSebastianelliAMetabolic syndrome and lower urinary tract symptoms: the role of inflammationProstate Cancer Prostatic Dis201316110110623165431
- VignozziLMorelliASarchielliETestosterone protects from metabolic syndrome-associated prostate inflammation: an experimental study in rabbitJ Endocrinol20122121718422010203
- GaoYWangMZhangHAre metabolic syndrome and its components associated with lower urinary tract symptoms? Results from a Chinese male population surveyUrology20127919420121924462
- HammarstenJHögstedtBHyperinsulinaemia as a risk factor for developing benign prostatic hyperplasiaEur Urol20013915115811223674
- SaadFGoorenLJThe role of testosterone in the etiology and treatment of obesity, the metabolic syndrome, and diabetes mellitus type 2J Obes20112011 Article ID 471584
- GuayATThe emerging link between hypogonadism and metabolic syndromeJ Androl20093037037618772486
- MulliganTFrickMFZurawQCStemhagenAMcWhirterCPrevalence of hypogonadism in males aged at least 45 years: the HIM studyInt J Clin Pract200660776276916846397
- El-SakkaAITayebKAErectile dysfunction risk factors in noninsulin dependent diabetic Saudi patientsJ Urol20031691043104712576842
- KaplanSWilsonTWAssociation between BPH and the metabolic syndrome in the REDUCE population [abstract 1548]J Urol20071774 suppl511
- MullerRGerberLMoreiraDObesity is associated with increased prostate growth and attenuated prostate volume reduction by dutasteride. Poster No 1736AUA Annual Meeting2012 May 19–23Atlanta, GA, USA
- LeeSHOhCYParkKKChungMSYooSJChungBHComparison of the clinical efficacy of medical treatment of symptomatic benign prostatic hyperplasia between normal and obese patientsAsian J Androl20111372873121499281
- ParsonsJKSarmaAVMcVaryKWeiJTObesity and benign prostatic hyperplasia: clinical connections, emerging etiological paradigms and future directionsJ Urol2009182S27S3119846130
- OzdenCOzdalOLUrganciogluGKoyuncuHGokkayaSMemisAThe correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasiaEur Urol20075119920316806666
- KetoCJMaskaEMFreedlandSJPhysical Activity, Obesity, and Lower Urinary Tract SymptomsEur Urol2011601181118321855211
- De NunzioCAronsonWFreedlandSJGiovannucciEParsonsJKThe correlation between metabolic syndrome and prostatic diseasesEur Urol201261356057022119157
- AUA Clinical Practice Guidelines [updated Sep 2010] Available from: http://www.auanet.org/content/clinical-practice-guidelines/clinical-guidelines/main-reports/bph-management/final_appendices.pdfAccessed August 22, 2012
- AUA Guideline on the Management of Erectile Dysfunction: Diagnosis and Treatment RecommendationsAmerican Urological Association Education and Research, Inc2005 Available from: http://www.auanet.org/content/clinical-practice-guidelines/clinical-guidelines/main-reports/edmgmt/chapter1.pdfAccessed August 22, 2012
- www.uroweb.org [webpage on the Internet]European Association of Urology Available from: http://www.uroweb.org/gls/pdf/14_Male%20Sexual%20Dysfunction_LR.pdfAccessed August 22, 2012